… symptoms or those with known heart disease, in whom the presence and … heart disease,
with or without symptoms of arrhythmia. The rationale for this testing is the evolution of disease …

… in 4444 patients with coronary heart disease: the … Disease(LIPID) Study Group: Prevention
of cardiovascular events and death with pravastatin in patients with coronary heart disease …

… Heart Association (www.americanheart.org). A single reprint of the executive summary and
… (US only) or writing the American Heart Association, Public Information, 7272 Greenville …

… atrial fibrillation (AF), because the executive summary contains mainly the recommendations.
… drugs and catheter ablation of AF in patients without and with structural heart disease. …

… When a recommendation is made to refer a patient to a specialist with expertise for further
evaluation, such as in the case of autonomic neurology, adult congenital heart disease (ACHD…

… Coronary heart disease is the leading cause of death among adult diabetics and accounts
for 3 times as many deaths among diabetics as among nondiabetics. While CABG carries an …

… Heart Disease includes a section that focuses on management of older adults.18 The guideline
acknowledges that, although there is strong rationale to treat ischemic heart disease (IHD…

… and/or estimation of prognosis in patients with known coronary artery disease or the
assessment of patients with known or suspected valvular heart disease.) (Level of Evidence: C) …

… (AHA) Task Force on Practice Guidelines was formed to make recommendations regarding
the diagnosis and treatment of patients with known or suspected cardiovascular disease. …

… heart disease will improve survival. Complications of cardiac catheterization include
respiratory depression due to the sedation, pneumothorax, arrhythmias, cardiac or vascular …